Validation of Androgen Receptor loss as a risk factor for the development of brain metastases from ovarian cancers

Validation of Androgen Receptor loss as a risk factor for the development of brain metastases from ovarian cancers

Abstract Background Central nervous system (CNS) spreading from epithelial ovarian carcinoma (EOC) is an uncommon but increasing phenomenon. We previously reported in a small series of 11 patients a correlation between Androgen Receptor (AR) loss and localization to CNS. Aims of this study were: to...

Description complète

Détails bibliographiques
Auteurs principaux: Gloria Mittica, Margherita Goia, Angela Gambino, Giulia Scotto, Mattia Fonte, Rebecca Senetta, Massimo Aglietta, Fulvio Borella, Anna Sapino, Dionyssios Katsaros, Furio Maggiorotto, Eleonora Ghisoni, Gaia Giannone, Valentina Tuninetti, Sofia Genta, Chiara Eusebi, Marina Momi, Paola Cassoni, Giorgio Valabrega
Format: Article
Langue:English
Publié: BMC 2020-05-01
Collection:Journal of Ovarian Research
Sujets:
Ovarian cancer
Brain metastases
Androgen receptor
Immunohistochemistry
Accès en ligne:http://link.springer.com/article/10.1186/s13048-020-00655-2

Internet

http://link.springer.com/article/10.1186/s13048-020-00655-2

Documents similaires